Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?

by Diana Hatoum, Eileen M. McGowan
Published 2015-01-01

Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence

by Eileen M. McGowan, Yiguang Lin, Diana Hatoum
Published 2018-05-01

Switching the Sphingolipid Rheostat in the Treatment of Diabetes and Cancer Comorbidity from a Problem to an Advantage

by Nikolas K. Haass, Najah Nassif, Eileen M. McGowan
Published 2015-01-01

Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19

by Eileen M McGowan, Nahal Haddadi, Najah T. Nassif, Yiguang Lin
Published 2020-09-01

Assessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug Screening.

by Sutthirat Udommethaporn, Tewin Tencomnao, Eileen M McGowan, Viroj Boonyaratanakornkit
Published 2016-01-01

Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer.

by Diana Hatoum, Daniel Yagoub, Alireza Ahadi, Najah T Nassif, Eileen M McGowan
Published 2017-01-01

An isomiR expression panel based novel breast cancer classification approach using improved mutual information

by Chaowang Lan, Hui Peng, Eileen M. McGowan, Gyorgy Hutvagner, Jinyan Li
Published 2018-12-01

“Dicing and Splicing” Sphingosine Kinase and Relevance to Cancer

by Nahal Haddadi, Yiguang Lin, Ann M. Simpson, Najah T. Nassif, Eileen M. McGowan
Published 2017-09-01

The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?

by David E. Moulder, Diana Hatoum, Enoch Tay, Yiguang Lin, Eileen M. McGowan
Published 2018-06-01

Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer

by Prangwan Pateetin, Gyorgy Hutvagner, Matthew P. Padula, Eileen M. McGowan, Viroj Boonyaratanakornkit
Published 2021-04-01

Hijacking of Endocrine and Metabolic Regulation in Cancer and Diabetes

by Eileen M. McGowan, Ann Simpson, James McManaman, Viroj Boonyaratanakornkit, Anandwardhan A. Hardikar
Published 2015-01-01

PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy

by Nahal Haddadi, Yiguang Lin, Glena Travis, Ann M. Simpson, Najah T. Nassif, Eileen M. McGowan
Published 2018-02-01

Author Correction: Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer

by Prangwan Pateetin, Gyorgy Hutvagner, Sarah Bajan, Matthew P. Padula, Eileen M. McGowan, Viroj Boonyaratanakornkit
Published 2021-05-01

p14ARF post-transcriptional regulation of nuclear cyclin D1 in MCF-7 breast cancer cells: discrimination between a good and bad prognosis?

by Eileen M McGowan, Nham Tran, Nikki Alling, Daniel Yagoub, Lisa M Sedger, Rosetta Martiniello-Wilks
Published 2012-01-01

Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases

by Hongjie Chen, Eileen M McGowan, Nina Ren, Sara Lal, Najah Nassif, Fatima Shad-Kaneez, Xianqin Qu, Yiguang Lin
Published 2018-07-01

Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay.

by Eileen M McGowan, Nikki Alling, Elise A Jackson, Daniel Yagoub, Nikolas K Haass, John D Allen, Rosetta Martinello-Wilks
Published 2011-01-01

Kinase-targeted cancer therapies: progress, challenges and future directions

by Khushwant S. Bhullar, Naiara Orrego Lagarón, Eileen M. McGowan, Indu Parmar, Amitabh Jha, Basil P. Hubbard, H. P. Vasantha Rupasinghe
Published 2018-02-01